Exelixis
EXEL
#1622
Rank
HK$104.15 B
Marketcap
HK$414.36
Share price
0.76%
Change (1 day)
25.08%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company